Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Research shows significant step toward improving outcomes, reducing treatment burden for SCD patients

Research shows significant step toward improving outcomes, reducing treatment burden for SCD patients

New approaches to treating leukemia, lymphoma and myeloma

New approaches to treating leukemia, lymphoma and myeloma

Experimental gene therapy may improve health outcomes for patients with some forms of blood disorders

Experimental gene therapy may improve health outcomes for patients with some forms of blood disorders

Lilly, Merck expand oncology clinical trial collaboration

Lilly, Merck expand oncology clinical trial collaboration

INP achieves 80% survival rate in acute lymphoblastic leukemia patients

INP achieves 80% survival rate in acute lymphoblastic leukemia patients

Study examines association between IV products and anaphylaxis risk

Study examines association between IV products and anaphylaxis risk

Rice University study examines variation between blood drops drawn from single fingerprick

Rice University study examines variation between blood drops drawn from single fingerprick

Viking submits IND application to FDA to conduct VK2809 Phase 2 study in patients with LDL-C and fatty liver disease

Viking submits IND application to FDA to conduct VK2809 Phase 2 study in patients with LDL-C and fatty liver disease

FDA grants accelerated approval for Darzalex to treat patients with multiple myeloma

FDA grants accelerated approval for Darzalex to treat patients with multiple myeloma

Drug combination produces long-term responses in patients with mantle cell lymphoma

Drug combination produces long-term responses in patients with mantle cell lymphoma

Boston Children's Hospital selects Vijay G. Sankaran to receive Rising Star Award

Boston Children's Hospital selects Vijay G. Sankaran to receive Rising Star Award

Phase I clinical trial shows investigational anticancer therapeutic is safe, tolerable in lymphoma patients

Phase I clinical trial shows investigational anticancer therapeutic is safe, tolerable in lymphoma patients

New clinical chemistry analyzer launched by EKF at Medica 2015

New clinical chemistry analyzer launched by EKF at Medica 2015

AACR rapid and dramatic responses in TRK fusion patients

AACR rapid and dramatic responses in TRK fusion patients

Agios announces data from dose-escalation phase 1 study of AG-120 in patients with IDH1 mutant positive advanced solid tumors

Agios announces data from dose-escalation phase 1 study of AG-120 in patients with IDH1 mutant positive advanced solid tumors

Stem-cell scientists discover new view of how human blood is made

Stem-cell scientists discover new view of how human blood is made

UCSD researchers suggest that cancer-related mutations common in patients with low blood counts

UCSD researchers suggest that cancer-related mutations common in patients with low blood counts

Researchers find strong associations between hunger and poor health

Researchers find strong associations between hunger and poor health

Lab experiment leads researchers to major red blood cell discovery

Lab experiment leads researchers to major red blood cell discovery

Deaths from avoidable risk factors: an interview with Dr Ali Mokdad, IHME

Deaths from avoidable risk factors: an interview with Dr Ali Mokdad, IHME

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.